3D Printed Drugs Market by Type, End Users, Key Players and Regions - Global Industry Analysis & Forecast to 2027

Published On : August 2022 Pages : 95 Category: Pharma & Healthcare Report Code : HC0817396

The global 3D Printed Drugs Market is valued at USD XX billion in 2021 and is projected to reach USD XX billion by the end of 2027, growing at a CAGR of XX% during the period 2022 to 2027.

The report exhibit detail coverage of 3D Printed Drugs industry and market trends. The report also analyses present and past market values to forecast potential market through the forecast period between 2017-2022. This research study of 3D Printed Drugs Market involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.

In addition, the report provides insight into main drivers, challenges, opportunities and risk of the market and strategies of suppliers. Key players are profiled as well. Overall, this report covers the historical situation, present status and the future prospects of the global 3D Printed Drugs Market for 2017-2022.

Crystal Market Research envisions that the span of the 3D Printed Drugs Market will develop amid the estimated time frame as the Compound Annual Growth Rate boosts significantly. The objective of the market research report is the current status of the market and in accordance classifies it into a few portions. The report takes into consideration the prime market players in every area from over the globe.

Our research study analyses the size of the global market of 3D Printed Drugs in primary regions such as North America, South America, Middle East & Africa, Asia Pacific and Europe. It also classifies the 3D Printed Drugs Market by key manufacturers, region, type and application. Furthermore, this study examines in the status of the market, market share, future trends, growth rate, competitive landscape, opportunities, market driving factors and restraints, and challenges.

To stay updated with the latest technology and functions of the industry, Crystal Market Research regularly performs interviews with several industry experts and visits for its expert research analysts. The data sources include but not limited to reports of company’s, international organizations and governments, MMI market surveys, and related industry news.

This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2017 to 2027. This report has segmented the 3D Printed Drugs Market on the basis of fabric, product, application, and region:

By Region

  • North America (US, Canada)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Mexico, Columbia, Rest of South America)
  • Middle East and Africa (Saudi Arabia, UAE, South Africa, Turkey, Rest of MEA)

Competitive Analysis                    

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • Aprecia Pharmaceuticals
  • GlaxoSmithKline Plc.
  • Hewlett Packard Caribe
  • 3D Printer Drug Machine
  • FabRx Ltd
  • Revolution Medicines

Market Classification

·        3D Printed Drugs Market, By Type, Estimates and Forecast, 2017-2022 ($Million)

o   Inkjet Printing

o   Fused Deposition Modeling

o   Stereolithography

o   ZipDose Technology

·        3D Printed Drugs Market, By End Users, Estimates and Forecast, 2017-2022 ($Million)

o   Hospitals & Clinics

o   Research Laboratories

o   Others

Table of Contents

1.     Introduction

1.1.  Report Description

1.2.  Research Methodology

1.2.1.     Data Mining

1.2.2.     Market Modeling and Forecasting

1.2.3.     Data Validation

1.2.4.     Industry Analysis

2.     Market Dashboard

3.     Market Overview

3.1.  Introduction

3.1.1.     Market Definition

3.1.2.     Market Segmentation

3.2.  Market Dynamics

3.2.1.     Drivers

3.2.2.     Restraints

3.2.3.     Opportunities

3.2.4.     Challenges

4.     3D Printed Drugs Market, By Type

4.1.  Introduction

4.2.  3D Printed Drugs Market and Market Growth Rate By Type (2017-2022)

4.3.  Inkjet Printing

4.3.1.     Global Inkjet Printing Market and Growth Rate (2017-2022)

4.3.  Fused Deposition Modeling

4.3.1.     Global Fused Deposition Modeling Market and Growth Rate (2017-2022)

4.3.  Stereolithography

4.3.1.     Global Stereolithography Market and Growth Rate (2017-2022)

4.3.  ZipDose Technology

4.3.1.     Global ZipDose Technology Market and Growth Rate (2017-2022)

5.     3D Printed Drugs Market, By End Users

5.1.  Introduction

5.2.  3D Printed Drugs Market and Market Growth Rate By End Users (2017-2022)

5.3.  Hospitals & Clinics

5.3.1.     Global Hospitals & Clinics Market and Growth Rate (2017-2022)

5.3.  Research Laboratories

5.3.1.     Global Research Laboratories Market and Growth Rate (2017-2022)

5.3.  Others

5.3.1.     Global Others Market and Growth Rate (2017-2022)

7.     3D Printed Drugs Market, By Region

7.1.  Introduction

7.2.  3D Printed Drugs Market and Growth Rate By Regions

6.3.  North America

7.3.1.     North America 3D Printed Drugs Market and Growth Rate (2017-2022))

7.3.2.     North America 3D Printed Drugs Market By Type (2017-2022)

7.3.2.     North America 3D Printed Drugs Market By End Users (2017-2022)

7.3.4.     North America 3D Printed Drugs Market By Country (2017-2022)

7.3.5.     United States

7.3.5.1.United States 3D Printed Drugs Market and Growth Rate (2017-2022)

7.3.5.2.United States 3D Printed Drugs Market By Type (2017-2022)

7.3.5.2.United States 3D Printed Drugs Market By End Users (2017-2022)

7.3.5.     Canada

7.3.5.1.Canada 3D Printed Drugs Market and Growth Rate (2017-2022)

7.3.5.2.Canada 3D Printed Drugs Market By Type (2017-2022)

7.3.5.2.Canada 3D Printed Drugs Market By End Users (2017-2022)

6.3.  Europe

8.3.1.     Europe 3D Printed Drugs Market and Growth Rate (2017-2022))

8.3.2.     Europe 3D Printed Drugs Market By Type (2017-2022)

8.3.2.     Europe 3D Printed Drugs Market By End Users (2017-2022)

8.3.4.     Europe 3D Printed Drugs Market By Country (2017-2022)

8.3.5.     Germany

8.3.5.1.Germany 3D Printed Drugs Market and Growth Rate (2017-2022)

8.3.5.2.Germany 3D Printed Drugs Market By Type (2017-2022)

8.3.5.2.Germany 3D Printed Drugs Market By End Users (2017-2022)

8.3.5.     France

8.3.5.1.France 3D Printed Drugs Market and Growth Rate (2017-2022)

8.3.5.2.France 3D Printed Drugs Market By Type (2017-2022)

8.3.5.2.France 3D Printed Drugs Market By End Users (2017-2022)

8.3.5.     UK

8.3.5.1.UK 3D Printed Drugs Market and Growth Rate (2017-2022)

8.3.5.2.UK 3D Printed Drugs Market By Type (2017-2022)

8.3.5.2.UK 3D Printed Drugs Market By End Users (2017-2022)

8.3.5.     Russia

8.3.5.1.Russia 3D Printed Drugs Market and Growth Rate (2017-2022)

8.3.5.2.Russia 3D Printed Drugs Market By Type (2017-2022)

8.3.5.2.Russia 3D Printed Drugs Market By End Users (2017-2022)

8.3.5.     Italy

8.3.5.1.Italy 3D Printed Drugs Market and Growth Rate (2017-2022)

8.3.5.2.Italy 3D Printed Drugs Market By Type (2017-2022)

8.3.5.2.Italy 3D Printed Drugs Market By End Users (2017-2022)

8.3.5.     Rest of Europe

8.3.5.1.Rest of Europe 3D Printed Drugs Market and Growth Rate (2017-2022)

8.3.5.2.Rest of Europe 3D Printed Drugs Market By Type (2017-2022)

8.3.5.2.Rest of Europe 3D Printed Drugs Market By End Users (2017-2022)

6.3.  Asia-Pacific

9.3.1.     Asia-Pacific 3D Printed Drugs Market and Growth Rate (2017-2022))

9.3.2.     Asia-Pacific 3D Printed Drugs Market By Type (2017-2022)

9.3.2.     Asia-Pacific 3D Printed Drugs Market By End Users (2017-2022)

9.3.4.     Asia-Pacific 3D Printed Drugs Market By Country (2017-2022)

9.3.5.     China

9.3.5.1.China 3D Printed Drugs Market and Growth Rate (2017-2022)

9.3.5.2.China 3D Printed Drugs Market By Type (2017-2022)

9.3.5.2.China 3D Printed Drugs Market By End Users (2017-2022)

9.3.5.     Japan

9.3.5.1.Japan 3D Printed Drugs Market and Growth Rate (2017-2022)

9.3.5.2.Japan 3D Printed Drugs Market By Type (2017-2022)

9.3.5.2.Japan 3D Printed Drugs Market By End Users (2017-2022)

9.3.5.     Korea

9.3.5.1.Korea 3D Printed Drugs Market and Growth Rate (2017-2022)

9.3.5.2.Korea 3D Printed Drugs Market By Type (2017-2022)

9.3.5.2.Korea 3D Printed Drugs Market By End Users (2017-2022)

9.3.5.     India

9.3.5.1.India 3D Printed Drugs Market and Growth Rate (2017-2022)

9.3.5.2.India 3D Printed Drugs Market By Type (2017-2022)

9.3.5.2.India 3D Printed Drugs Market By End Users (2017-2022)

9.3.5.     Southeast Asia

9.3.5.1.Southeast Asia 3D Printed Drugs Market and Growth Rate (2017-2022)

9.3.5.2.Southeast Asia 3D Printed Drugs Market By Type (2017-2022)

9.3.5.2.Southeast Asia 3D Printed Drugs Market By End Users (2017-2022)

9.3.5.     Rest of Asia-Pacific

9.3.5.1.Rest of Asia-Pacific 3D Printed Drugs Market and Growth Rate (2017-2022)

9.3.5.2.Rest of Asia-Pacific 3D Printed Drugs Market By Type (2017-2022)

9.3.5.2.Rest of Asia-Pacific 3D Printed Drugs Market By End Users (2017-2022)

6.3.  South America

10.3.1.     South America 3D Printed Drugs Market and Growth Rate (2017-2022))

10.3.2.     South America 3D Printed Drugs Market By Type (2017-2022)

10.3.2.     South America 3D Printed Drugs Market By End Users (2017-2022)

10.3.4.     South America 3D Printed Drugs Market By Country (2017-2022)

10.3.5.     Brazil

10.3.5.1.Brazil 3D Printed Drugs Market and Growth Rate (2017-2022)

10.3.5.2.Brazil 3D Printed Drugs Market By Type (2017-2022)

10.3.5.2.Brazil 3D Printed Drugs Market By End Users (2017-2022)

10.3.5.     Mexico

10.3.5.1.Mexico 3D Printed Drugs Market and Growth Rate (2017-2022)

10.3.5.2.Mexico 3D Printed Drugs Market By Type (2017-2022)

10.3.5.2.Mexico 3D Printed Drugs Market By End Users (2017-2022)

10.3.5.     Columbia

10.3.5.1.Columbia 3D Printed Drugs Market and Growth Rate (2017-2022)

10.3.5.2.Columbia 3D Printed Drugs Market By Type (2017-2022)

10.3.5.2.Columbia 3D Printed Drugs Market By End Users (2017-2022)

10.3.5.     Rest of South America

10.3.5.1.Rest of South America 3D Printed Drugs Market and Growth Rate (2017-2022)

10.3.5.2.Rest of South America 3D Printed Drugs Market By Type (2017-2022)

10.3.5.2.Rest of South America 3D Printed Drugs Market By End Users (2017-2022)

6.3.  Middle East and Africa

11.3.1.     Middle East and Africa 3D Printed Drugs Market and Growth Rate (2017-2022))

11.3.2.     Middle East and Africa 3D Printed Drugs Market By Type (2017-2022)

11.3.2.     Middle East and Africa 3D Printed Drugs Market By End Users (2017-2022)

11.3.4.     Middle East and Africa 3D Printed Drugs Market By Country (2017-2022)

11.3.5.     Saudi Arabia

11.3.5.1.Saudi Arabia 3D Printed Drugs Market and Growth Rate (2017-2022)

11.3.5.2.Saudi Arabia 3D Printed Drugs Market By Type (2017-2022)

11.3.5.2.Saudi Arabia 3D Printed Drugs Market By End Users (2017-2022)

11.3.5.     United Arab Emirates

11.3.5.1.United Arab Emirates 3D Printed Drugs Market and Growth Rate (2017-2022)

11.3.5.2.United Arab Emirates 3D Printed Drugs Market By Type (2017-2022)

11.3.5.2.United Arab Emirates 3D Printed Drugs Market By End Users (2017-2022)

11.3.5.     South Africa

11.3.5.1.South Africa 3D Printed Drugs Market and Growth Rate (2017-2022)

11.3.5.2.South Africa 3D Printed Drugs Market By Type (2017-2022)

11.3.5.2.South Africa 3D Printed Drugs Market By End Users (2017-2022)

11.3.5.     Rest of Middle East and Africa

11.3.5.1.Rest of Middle East and Africa 3D Printed Drugs Market and Growth Rate (2017-2022)

11.3.5.2.Rest of Middle East and Africa 3D Printed Drugs Market By Type (2017-2022)

11.3.5.2.Rest of Middle East and Africa 3D Printed Drugs Market By End Users (2017-2022)

7.     Company Profiles

7.1.  Aprecia Pharmaceuticals

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  GlaxoSmithKline Plc.

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  Hewlett Packard Caribe

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  3D Printer Drug Machine

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  FabRx Ltd

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  Revolution Medicines

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*